Louis Brenner, Hopewell Therapeutics CEO

LNP biotech looks to go be­yond the liv­er, rais­ing $25M in seed mon­ey to move for­ward

Hopewell Ther­a­peu­tics an­nounced $25 mil­lion in seed fund­ing on Wednes­day, with the Boston-area biotech look­ing to make the next break­through in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.